Polyclonal Antibody to Preferentially Expressed Antigen In Melanoma (PRAME)
  • Polyclonal Antibody to Preferentially Expressed Antigen In Melanoma (PRAME)

Polyclonal Antibody to Preferentially Expressed Antigen In Melanoma (PRAME)

Ref: CC-PAH323Hu02-200 ul
MAPE; OIP4; CT130; Cancer/Testis Antigen 130; Opa-interacting protein 4; Melanoma antigen preferentially expressed in tumors

Información del producto

Información adicional
Size 200 ul
Applications WB
Detection Range Rabbit
Sensitivity 200 ul
Research Area Tumor immunity
Immunogen RPH323Hu02-Recombinant Preferentially Expressed Antigen In Melanoma (PRAME)
Organism species Homo sapiens (Human)
Alternative Names MAPE
Item Name Preferentially Expressed Antigen In Melanoma
Assay Length Tumor immunity
Sample Type WB
Host Rabbit
Test Principle Ra
Assay procedure summary Western blotting: 0.5-2µg/mL
UniProt ID P78395
Buffer Formulation PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Usage Western blotting: 0.01-2µg/mL
Tissue Source Polyclonal antibody preparation
Reactivity Ra